This paper will overview our results of endovascular therapy (PTA or stenting) for cervical ICA stenosis and discuss the advantages and disadvantages of each treatment. 60 cases with 62 lesions were treated with PTA 68 times, while 36 cases with 37 lesions were treated with stenting 37 times. A total of 99 lesions were treated with PTA or stenting 105 times. In the PTA group arterial stenosis improved from 76.4% to 21%. In the stent group the stenosis improved from 82.3% to 8.3%. The morbidity rate was 2/60 (3.3%) in PTA group, although two cases had minor neurological deficits, while in stent treated group, morbidity rate was 1/36 (2.8%), although it showed one major neurological deficit. Mortality was 0% in each group. The restenosis rate in PTA group was 15/58 (26%), while it was 0/20 (0%) in stent treated group. Stenting brings significant reduction of stenosis and reduces the rate of restenosis compared to PTA. However, stenting has its own disadvantages such as hypotension and distal kinks when deployed in tortuous ICA stenosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685926 | PMC |
| http://dx.doi.org/10.1177/15910199000060S139 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Endovascular intravascular intervention for central venous stenosis in maintenance hemodialysis patients: a retrospective observational study.
Front Cardiovasc Med
December 2024
Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Background: The number of people undergoing maintenance hemodialysis is increasing rapidly worldwide. Central vein stenosis (CVS) is a common vascular complication in undergoing hemodialysis, especially those with a history of catheterization. This study aimed to investigate the characteristics of CVS and the clinical effectiveness of percutaneous transluminal angioplasty (PTA) alone and sequential percutaneous transluminal stenting (PTS) in hemodialysis patients with CVS.
View Article and Find Full Text PDFLong-term efficacy of subclavian vein stenting in a patient on hemodialysis complicated by stasis dermatitis due to subclavian vein stenosis.
J Cardiol Cases
December 2024
Department of Cardiology, Japanese Red Cross Ashikaga Hospital, Ashikaga, Japan.
Unlabelled: Data about the long-term safety and efficacy of stent implantation for central venous stenosis in patients on dialysis are limited. We report the case of a 66-year-old man on hemodialysis for end-stage renal disease who presented with stasis dermatitis around an arteriovenous shunt with ulceration of the left forearm. Computed tomography angiography showed a tight stenosis of the proximal left subclavian vein and the development of collateral blood vessels around the stenosis.
View Article and Find Full Text PDFChronic total occlusion of renal artery in symptomatic young patient with resistant hypertension: is a revascularization necessary or redundant?
J Hypertens
January 2025
Department of Photomedicine and Physical Chemistry, Medical College of The Rzeszów University, Rzeszów, Poland.
Article Synopsis
- Renal artery stenosis (RAS) is a condition where the renal artery is narrowed by 60% or more, most commonly due to atherosclerotic plaques, affecting 5-10% of the population; rare causes include fibromuscular dysplasia and vasculitis.
- The standard diagnostic method for RAS is digital subtraction angiography (DSA), but other imaging techniques like Doppler ultrasonography and CT angiography are also important.
- Treatment typically involves percutaneous transluminal angioplasty (PTA), and a case study highlights a 19-year-old patient who benefitted from using a paclitaxel-coated balloon to restore renal artery function and reduce hypertension.
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on the TOBA II Study.
J Comp Eff Res
January 2025
Division of Vascular & Endovascular Surgery, University of California San Francisco, San Francisco, CA USA.
Article Synopsis
- Percutaneous transluminal angioplasty (PTA) for peripheral artery disease often results in vascular dissections, increasing the need for additional interventions (target lesion revascularization or TLR).
- A study using a decision-analytic model analyzed the clinical outcomes, costs, and quality of life impacts of using the Tack Endovascular System versus the standard PTA approach, showing lower TLR rates with the Tack-supported strategy.
- The results suggest that focal stenting (using Tack) is cost-effective for non-severe dissections and may even save costs for severe cases while improving patient quality of life, highlighting potential economic benefits in managing dissections post-PTA.
Intravascular Ultrasound Assessment of Arterial Dissections Following Rotarex Atherectomy: Results of the iDissection Rotarex Study.
J Soc Cardiovasc Angiogr Interv
September 2024
Cardiovascular Research Department, Midwest Cardiovascular Research Foundation, Davenport, Iowa.
Background: There are limited data on the mechanism of the Rotarex Rotational Excisional Atherectomy System in treating femoropopliteal arterial disease. The Rotarex iDissection study is a prospective, single center study evaluating the extent of excision and dissection in de novo and restenotic (not in-stent) lesions of the femoropopliteal arteries in symptomatic peripheral arterial disease patients.
Methods: Consecutive patients with symptomatic peripheral arterial disease were prospectively enrolled in the Rotarex iDissection study at a single US center after obtaining informed consent.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!